Objective: To assess the cost-effectiveness of polymerase chain reaction (PCR) compared to flow cytometry to detect minimal residual disease at the end of induction in acute lymphoid leukemia (ALL) patients under 18 years old.Methods: A decision tree was built in TreeAge®, with outcome measured...

ResumenObjetivoEstimar la razón de costo-efectividad de diferentes esquemas diagnósticos en recién nacidos de madres con historia clínica de infección por Toxoplasma gondii durante el embarazo, para aumentar los casos detectados de toxoplasmosis congénita.MétodosSe construyó un árbol de...

ResumenObjetivo: Estimar la razón de costo efectividad de realizar la tamización serológica para toxoplasma en el primer control prenatal y continuar o no con seguimiento mensual o trimestral, para aumentar los casos diagnosticados de gestantes con infección por Toxoplasma gondii con...

ResumenObjetivoEstimar la razón de costo efectividad del urocultivo, la tinción de Gram o el parcial de orina solos, comparados con el urocultivo dependiendo del resultado del parcial de orina, para la tamización de bacteriuria asintomática (BAS) en mujeres embarazadas.MétodosSe diseñaron...

This report presents a computer model for evaluating the cost-effectiveness (CE) of Hormone Replacement Therapy (HRT). The model is an extension of a previous model and includes also the risk of spine and wrist fracture. New Swedish data on risk of coronary heart disease and related mortality...

Objective: To estimate the cost-effectiveness of the supply of calcium of 1200mg per day from the week 14 of pregnancy to all pregnant women compared to not supplying it to reduce the incidence of preeclampsia. Methods: A decision tree was built in TreeAge® with outcome measured in life years...

Cost-effectiveness analysis is versatile and used widely to assist in health care decision making. This chapter discusses how cost-effectiveness analysis is used at the system or national level, particularly in the domain of coverage and payment policy. We describe its relationship to other...

This report presents a computer model for evaluating the cost-effectiveness (CE) of Hormone Replacement Therapy (HRT). The model is an extension of a previous model and includes also the risk of spine and wrist fracture. New Swedish data on risk of coronary heart disease and related mortality...

The cost-effectiveness of hormone replacement therapy (HRT) based on a societal perspective is reassessed based on new medical evidence found in the Women’s Health Initiative (WHI). Within a model framework using an individual state transition model the cost-effectiveness of 50-60 year old...

Objetive: To conduct a cost-effectiveness analysis comparing tamoxifen and aromatase inhibitors in adyuvant treatment of hormone receptor-positive, post-menopausal early breast cancer patients.Methods: Effectivity was defined as disease-free survival. By means of a Markov model we estimated the...